Figure 1.
Unsupervised analysis does not distinguish HLH from sepsis/SIRS compared with pediatric controls. (A) Heat map displaying unsupervised clustering of all plasma analytes assayed from noninflammatory pediatric controls, HLH, sepsis, and SIRS. Colors representing specific diagnostic groups/subgroups are included in the legend. Cases of secondary HLH (systemic juvenile idiopathic arthritis [JIA], drug reaction with eosinophilia syndrome [DRESS], and cancer) are indicated. (B) These datasets are also presented using principal component analysis. The control cases clearly separate, whereas HLH, severe sepsis, and SIRS have overlapping inflammatory plasma profiles.

Unsupervised analysis does not distinguish HLH from sepsis/SIRS compared with pediatric controls. (A) Heat map displaying unsupervised clustering of all plasma analytes assayed from noninflammatory pediatric controls, HLH, sepsis, and SIRS. Colors representing specific diagnostic groups/subgroups are included in the legend. Cases of secondary HLH (systemic juvenile idiopathic arthritis [JIA], drug reaction with eosinophilia syndrome [DRESS], and cancer) are indicated. (B) These datasets are also presented using principal component analysis. The control cases clearly separate, whereas HLH, severe sepsis, and SIRS have overlapping inflammatory plasma profiles.

Close Modal

or Create an Account

Close Modal
Close Modal